Skip to main content

Roche Holding AG

corporate_fare Company Profile

Roche Holding AG

RHHBY·OTC·Life Sciences·CIK 0001499655

Roche Holding AG is a global healthcare company operating in the pharmaceuticals and diagnostics sectors. The company provides pharmaceutical solutions across a wide range of therapeutic areas, including anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune conditions, neurological disorders, ophthalmology, respiratory disorders, and transplantation. In its diagnostics business, Roche Holding AG offers in vitro tests for the diagnosis of various diseases such as cancer, diabetes, Covid-19, hepatitis, and human papillomavirus, among others. It also provides diagnostic instruments and digital health solutions. Geographically, Roche Holding AG conducts business in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company has a collaboration agreement with Excalipoint Therapeutics to evaluate EXP011 in DLL3-expressing solid tumors. Founded in 1896, Roche Holding AG is based in Basel, Switzerland.

Roche Holding AG (OTC:RHHBY) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 11 items for RHHBY at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-16, rated 7/10. Across its 11 most recent items scored 7 or higher, the top rating is 8/10, with 4 rated 8 or above.

Recent high-impact activity:

  • Gazyva Wins First-Ever FDA Approval for Primary Membranous Nephropathy
  • Divarasib Cuts Death Risk 44% vs Standard KRAS Drugs in Phase III Lung Cancer Trial
  • Sefaxersen Cuts Proteinuria 43% in Phase III IgA Nephropathy Trial
  • Roche Q3 Revenue Tops Consensus at CHF16.13B, Guidance Confirmed
  • FDA Approves First At-Home Subcutaneous Treatment for Thyroid Eye Disease

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 2,892,550 shares in RHHBY as of the October 30, 2026 settlement, a 5.2% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 12.7% of RHHBY volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)2,892,550 shares as of October 30, 2026
Change vs prior period▲ 5.2%
Days to cover1.00 at avg daily volume of 2,999,548
Daily short volume (FINRA facilities)12.7% of 1,827,741 shares on November 20, 2026
5-day average short volume20.8%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with R →
$58.46
52-week range · as of 2026-11-16 $44.57 – $61.75
Market cap
$374.65B
Volume
1.8M (1.3× avg)
3-mo avg 1.4M
Live data · 2026-11-21 10:37 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed RHHBY - Latest Insights

RHHBY
Nov 16, 2026, 1:00 AM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $60.30
Real-time Price: $58.46 info
Change: -$1.84 (-3%) info
Market Cap: $374.649B info
RHHBY
Oct 25, 2026, 11:30 AM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $61.17
Real-time Price: $58.46 info
Change: -$2.71 (-4%) info
Market Cap: $374.649B info
RHHBY
Oct 23, 2026, 1:30 PM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $60.19
Real-time Price: $58.46 info
Change: -$1.73 (-3%) info
Market Cap: $374.649B info
RHHBY
Oct 22, 2026, 12:50 PM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $59.48
Real-time Price: $58.46 info
Change: -$1.02 (-2%) info
Market Cap: $374.649B info
RHHBY
Oct 16, 2026, 1:00 AM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $56.78
Real-time Price: $58.46 info
Change: +$1.68 (+3%) info
Market Cap: $374.649B info
RHHBY
Oct 10, 2026, 5:40 PM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $54.09
Real-time Price: $58.46 info
Change: +$4.37 (+8%) info
Market Cap: $374.649B info
RHHBY
Oct 08, 2026, 3:26 PM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $53.35
Real-time Price: $58.46 info
Change: +$5.11 (+10%) info
Market Cap: $374.649B info
RHHBY
Oct 01, 2026, 2:00 AM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $51.88
Real-time Price: $58.46 info
Change: +$6.58 (+13%) info
Market Cap: $374.649B info
RHHBY
Oct 01, 2026, 1:00 AM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $51.88
Real-time Price: $58.46 info
Change: +$6.58 (+13%) info
Market Cap: $374.649B info
RHHBY
Sep 30, 2026, 1:00 AM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $52.25
Real-time Price: $58.46 info
Change: +$6.21 (+12%) info
Market Cap: $374.649B info
RHHBY
Sep 21, 2026, 1:04 PM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $55.36
Real-time Price: $58.46 info
Change: +$3.10 (+6%) info
Market Cap: $374.649B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets